ANIP: Multiplikator P/S ANI Pharma
ANI Pharmaceuticals is implementing packaging and encapsulation automation to reduce personnel costs. The company also utilizes third-party contractors for product manufacturing and pharmacy distribution. The current P/S multiple, with GURU.Markets data illustrated on this chart, is characterized by 1.60 setting the current value of the metric. The firm successfully combines the production of generics with the sale of profitable orphan drugs.
Rincian metrik lan analitis perusahaan ANI Pharma (ANIP)
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Rasio Kabeh Utang marang Dana Pribadi ANI Pharmaceuticals|ANIP - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas ANI Pharmaceuticals Corp|ANIP - Gunggung utang perusahaan|Rasio utang marang aset resik ANI Pharma|ANIP - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ANI Pharmaceuticals|Rasio jangkoan perantara anipharmaceuticals.com
- indikator pendapatan resik lan kelipatan nilai:
ANIP - Bathi resik perusahaan|Bathi mangsa ngarep ANI Pharmaceuticals|ANIP - Pangali P/E|Pangali Forward P/E ANI Pharmaceuticals Inc|ANIP - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ANI Pharma|ANIP - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan ANI Pharmaceuticals|ANIP - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan anipharmaceuticals.com|ANIP - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep ANI Pharmaceuticals
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:anipharmaceuticals.com, ANIP
For ANI Pharmaceuticals (ANIP), which combines in-house capacities with GMP-standard outsourced production, the P/S multiple serves as a key tool for evaluating revenue generation efficiency. By analyzing the current P/S valuation, an investor compares market capitalization with actual sales volume, allowing them to filter out speculative noise and determine the fair value of the business relative to its operational scale.
Perusahaan pesaing
HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S KVUE (Kenvue)|Multiplikator P/S Verona Pharma PLC VRNA|MENS - Rasio rega marang pendapatan|LGND (Ligand Corp) - Rasio kapitalisasi marang pendapatan|AMRX: Multiplikator P/S|PRGO - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan ALVO|LQDA: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Galapagos Genomics (GLPG)|MNKD: Rasio rega marang dodolan|Multiplikator P/S AMPH (Amphastar Pharmaceuticals)|Rasio kapitalisasi pasar marang pendapatan PCRX|ARS Pharmaceuticals, Inc. - Multiplikator P/S|TBPH - Multiplikator P/S|Aquestive Pharma (AQST) - Rasio rega marang pendapatan|scPharmaceuticals - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Tectonic Therapeutic Inc.|Kapitalisasi marang pendapatan tonixpharma.com (TNXP)|Multiplikator P/S SXTC|Multiplikator P/S eupraxiapharma.com (EPRX)|Multiplikator P/S BHST (BioHarvest)|EXOZ - Kapitalisasi marang pendapatan|Oramed Pharma - Multiplikator P/S|Rega marang dodolan Entera Bio Ltd.|HYFT (MindWalk Holdings Inc.) - Kapitalisasi marang pendapatan|ABVC BioPharma Inc. (ABVC) - Multiplikator P/S|Kapitalisasi marang pendapatan CPIX|QNTM (Quantum BioPharma Corp) - Kapitalisasi marang volume dodolan|Multiplikator P/S FGEN|Koefisien rega marang pendapatan telomirpharma.com|Multiplikator P/S RANI (Rani Therapeutics Holdings, Inc.)|SNYR - Kapitalisasi marang pendapatan|Rallybio Corp. - Multiplikator P/S|LEXX - Multiplikator P/S|Pulmatrix, Inc. (PULM) - Rasio rega marang pendapatan|PTHL (Pheton Holdings) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Aptorum Group Ltd|Lyra Therapeutics Inc. (LYRA) - Koefisien rega marang pendapatan|Multiplikator P/S IBO|Multiplikator P/S tnfpharma.com (TNFA)|Rasio rega marang pendapatan cbdMD YCBD|PRFX: Rasio kapitalisasi marang pendapatan|Auris Medical - Multiplikator P/S|Koefisien rega marang pendapatan Lipella Pharmaceuticals Inc LIPO|Optinose (OPTN) - Rasio rega marang pendapatan|Rasio rega marang dodolan PIRS (Pieris Pharma)|Rasio rega marang pendapatan Procaps Group S.A.|petrospharma.com - Rasio rega marang dodolan|Multiplikator P/S QLI|SLRN (Acelyrin Inc.) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S TFFP (TFF Pharma)
